Rapid diagnostics

DEVICE3 trials

Conditions

Acute GastroenteritisBlood Stream InfectionsCarbapenem-Resistant Enterobacteriaceae InfectionChronic Obstructive Pulmonary Disease ExacerbationHealthcare Associated InfectionHospital-acquired PneumoniaPneumoniaRespiratory Tract Infections

Phase 3

Optimizing the Management of Acute Diarrhoeal Disease

CompletedNCT02803827

Hamilton Health Sciences CorporationAcute Gastroenteritis

Start: 2016-06-30End: 2019-02-28Updated: 2019-02-26

Phase 4

EaRly impAct theraPy With Ceftazidime-avibactam Via rapID Diagnostics

RecruitingNCT05979545

National University of SingaporeBlood Stream Infections, Carbapenem-Resistant Enterobacteriaceae Infection, Healthcare Associated Infection +2

Start: 2023-12-12End: 2026-12-31Target: 1900Updated: 2024-03-06

Unknown Phase

Improved Diagnostics, Treatment and Follow-up of Acute Exacerbation of Chronic Obstructive Pulmonary Disease

Not yet recruitingNCT06105814

Vestre Viken Hospital TrustChronic Obstructive Pulmonary Disease Exacerbation, Pneumonia, Respiratory Tract Infections

Start: 2024-01-01End: 2030-12-31Target: 200Updated: 2023-10-30

Related Papers

Minimal Impact on the Resistome of Children in Botswana After Azithromycin Treatment for Acute Severe Diarrheal Disease.

2024-07-012 citations

Optimising the management of childhood acute diarrhoeal disease using a rapid test-and- treat strategy and/or <i>Lactobacillus reuteri</i> DSM 17938: a multicentre, randomised, controlled, factorial trial in Botswana